Liquim is an Australian commercial-stage company developing plant-based barriers — for industry, healthcare and procurement teams with environmental, social and governance (ESG) targets.
Commercial stageProducts in market
admin@liquim.com.auAnnouncements
Corporate updates and commercial milestones, delivered direct.
© 2026 Liquim Ltd·3/190 Main Street, Osborne Park, WA 6017·ABN 35 641 620 368·ACN 641 620 368
Wholesale investor notice. Investor materials and capital-raising communications are made available only to persons qualifying as wholesale or sophisticated investors under sections 708(8) or 708(11) of the Corporations Act 2001 (Cth).
Forward-looking statements (ASX guidance). This site contains forward-looking statements concerning Liquim Ltd's proposed listing on the Australian Securities Exchange, product pipeline, regulatory pathway and commercial timing. These statements are based on assumptions and information available at the time of preparation and are subject to known and unknown risks, uncertainties and other factors, many of which are outside the company's control. Actual results, performance or achievements may differ materially from those expressed or implied. A proposed ASX listing is subject to regulatory, market and ASX admission requirements and is not guaranteed. Nothing on this site constitutes financial product advice, an offer of securities or an invitation to apply for securities; any offer will be made only under a disclosure document or other offer document lodged with the relevant authority. The information is general in nature and does not take into account any particular investor's objectives, financial situation or needs.
Product & regulatory notice. Liquim supplies its products in Australia. Respi-VIVA is listed on the Australian Register of Therapeutic Goods (AUSTL 437515). RevoGlov is a cosmetic-classified product and is not a therapeutic good. Other applications of the microfilm technology described on this site are in development and are not products on sale. Statements about barrier performance refer to independent laboratory testing and describe how the film behaved in those tests only; they are not claims of efficacy in preventing infection or disease in humans, and no protection against viruses is claimed. Products are not intended to diagnose, treat, cure or prevent any disease. Consumers should follow product labelling and consult a healthcare professional where appropriate. Issued by Liquim Ltd.